...
首页> 外文期刊>Critical care : >Multiple-center evaluation of mortality associated with acute kidney injury in critically ill patients: a competing risks analysis
【24h】

Multiple-center evaluation of mortality associated with acute kidney injury in critically ill patients: a competing risks analysis

机译:重症患者急性肾脏损伤相关死亡率的多中心评估:竞争风险分析

获取原文

摘要

IntroductionIn this study, we aimed to assess the association between acute kidney injury (AKI) and mortality in critically ill patients using an original competing risks approach.MethodsUnselected patients admitted between 1997 and 2009 to 13 French medical or surgical intensive care units were included in this observational cohort study. AKI was defined according to the RIFLE criteria. The following data were recorded: baseline characteristics, daily serum creatinine level, daily Sequential Organ Failure Assessment (SOFA) score, vital status at hospital discharge and length of hospital stay. Patients were classified according to the maximum RIFLE class reached during their ICU stay. The association of AKI with hospital mortality with "discharge alive" considered as a competing event was assessed according to the Fine and Gray model.ResultsOf the 8,639 study patients, 32.9% had AKI, of whom 19.1% received renal replacement therapy. Patients with AKI had higher crude mortality rates and longer lengths of hospital stay than patients without AKI. In the Fine and Gray model, independent risk factors for hospital mortality were the RIFLE classes Risk (sub-hazard ratio (SHR) 1.58 and 95% confidence interval (95% CI) 1.32 to 1.88; P < 0.0001), Injury (SHR 3.99 and 95% CI 3.43 to 4.65; P < 0.0001) and Failure (SHR 4.12 and 95% CI 3.55 to 4.79; P < 0.0001); nonrenal SOFA score (SHR 1.19 per point and 95% CI 1.18 to 1.21; P < 0.0001); McCabe class 3 (SHR 2.71 and 95% CI 2.34 to 3.15; P < 0.0001); and respiratory failure (SHR 3.08 and 95% CI 1.36 to 7.01; P < 0.01).ConclusionsBy using a competing risks approach, we confirm in this study that AKI affecting critically ill patients is associated with increased in-hospital mortality.
机译:前言在本研究中,我们旨在使用原始竞争风险方法评估危重患者的急性肾损伤(AKI)与死亡率之间的关系。方法1997年至2009年之间入选13个法国医疗或外科重症监护病房的未选患者包括在本研究中观察性队列研究。 AKI是根据RIFLE标准定义的。记录以下数据:基线特征,每日血清肌酐水平,每日序贯器官衰竭评估(SOFA)评分,出院时的生命状态和住院时间。根据在ICU住院期间达到的最大RIFLE分类对患者进行分类。根据Fine和Grey模型评估了AKI与医院死亡率与“存活出院”的竞争关系。结果在8639名研究患者中,有32.9%患有AKI,其中19.1%接受了肾脏替代治疗。与没有AKI的患者相比,患有AKI的患者的死亡率更高,住院时间更长。在Fine和Grey模型中,医院死亡的独立危险因素为RIFLE类风险(亚危险比(SHR)1.58和95%置信区间(95%CI)1.32至1.88; P <0.0001),伤害(SHR 3.99)和95%CI 3.43至4.65; P <0.0001)和失败(SHR 4.12和95%CI 3.55至4.79; P <0.0001);非肾SOFA评分(每点SHR 1.19和95%CI 1.18至1.21; P <0.0001); McCabe 3级(SHR 2.71和95%CI 2.34至3.15; P <0.0001);结论:通过使用竞争风险方法,我们在这项研究中证实,影响重症患者的AKI与住院死亡率增加有关。危险因素(SHR 3.08 and 95%CI 1.36 to 7.01; P <0.01)。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号